218 related articles for article (PubMed ID: 26579494)
1. Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells.
Reuter D; Staege MS; Kühnöl CD; Föll J
Front Oncol; 2015; 5():242. PubMed ID: 26579494
[TBL] [Abstract][Full Text] [Related]
2. OX40/OX40 ligand and its role in precision immune oncology.
Thapa B; Kato S; Nishizaki D; Miyashita H; Lee S; Nesline MK; Previs RA; Conroy JM; DePietro P; Pabla S; Kurzrock R
Cancer Metastasis Rev; 2024 Mar; ():. PubMed ID: 38526805
[TBL] [Abstract][Full Text] [Related]
3. In Situ Reprogramming of Tumors for Activating the OX40/OX40 Ligand Checkpoint Pathway and Boosting Antitumor Immunity.
Gao Y; Zhao J; Huang Z; Zhao H; Guo Z; Ma S; Tang X; Song W; Chen X
ACS Biomater Sci Eng; 2023 Jul; 9(7):4108-4116. PubMed ID: 35653749
[TBL] [Abstract][Full Text] [Related]
4. Characterization of rat OX40 ligand by monoclonal antibody.
Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine-2,3-dioxygenase in an immunotherapy model for Ewing sarcoma.
Max D; Kühnöl CD; Burdach S; Niu L; Staege MS; Föll JL
Anticancer Res; 2014 Nov; 34(11):6431-41. PubMed ID: 25368243
[TBL] [Abstract][Full Text] [Related]
6. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
7. OX40 and OX40L Interaction in Cancer.
Lu X
Curr Med Chem; 2021; 28(28):5659-5673. PubMed ID: 33372866
[TBL] [Abstract][Full Text] [Related]
8. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
Wang HC; Klein JR
J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
[TBL] [Abstract][Full Text] [Related]
9. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
Ukyo N; Hori T; Yanagita S; Ishikawa T; Uchiyama T
Immunology; 2003 Jun; 109(2):226-31. PubMed ID: 12757617
[TBL] [Abstract][Full Text] [Related]
10. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice.
Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K
Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678
[TBL] [Abstract][Full Text] [Related]
11. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis.
Ndhlovu LC; Ishii N; Murata K; Sato T; Sugamura K
J Immunol; 2001 Sep; 167(5):2991-9. PubMed ID: 11509650
[TBL] [Abstract][Full Text] [Related]
12. The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia.
Nuebling T; Schumacher CE; Hofmann M; Hagelstein I; Schmiedel BJ; Maurer S; Federmann B; Rothfelder K; Roerden M; Dörfel D; Schneider P; Jung G; Salih HR
Cancer Immunol Res; 2018 Feb; 6(2):209-221. PubMed ID: 29321210
[TBL] [Abstract][Full Text] [Related]
13. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
[TBL] [Abstract][Full Text] [Related]
14. Identification of rat OX40 ligand by molecular cloning.
Akiba H; Atsuta M; Yagita H; Okumura K
Biochem Biophys Res Commun; 1998 Oct; 251(1):131-6. PubMed ID: 9790919
[TBL] [Abstract][Full Text] [Related]
15. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis.
Pollmann J; Götz JJ; Rupp D; Strauss O; Granzin M; Grünvogel O; Mutz P; Kramer C; Lasitschka F; Lohmann V; Björkström NK; Thimme R; Bartenschlager R; Cerwenka A
J Hepatol; 2018 Mar; 68(3):421-430. PubMed ID: 29100993
[TBL] [Abstract][Full Text] [Related]
17. The significance of OX40 and OX40L to T-cell biology and immune disease.
Croft M; So T; Duan W; Soroosh P
Immunol Rev; 2009 May; 229(1):173-91. PubMed ID: 19426222
[TBL] [Abstract][Full Text] [Related]
18. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
Soroosh P; Ine S; Sugamura K; Ishii N
J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
[TBL] [Abstract][Full Text] [Related]
19. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response.
Stüber E; Strober W
J Exp Med; 1996 Mar; 183(3):979-89. PubMed ID: 8642301
[TBL] [Abstract][Full Text] [Related]
20. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand.
Baba E; Takahashi Y; Lichtenfeld J; Tanaka R; Yoshida A; Sugamura K; Yamamoto N; Tanaka Y
J Immunol; 2001 Jul; 167(2):875-83. PubMed ID: 11441094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
